Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 in hematopoietic cell transplant recipients.
Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Akunal A, Birinci S; Turkish Ministry of Health, Hematology Scientific Working Group. Altuntas F, et al. Bone Marrow Transplant. 2021 Apr;56(4):952-955. doi: 10.1038/s41409-020-01084-x. Epub 2020 Oct 28. Bone Marrow Transplant. 2021. PMID: 33110186
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers.
Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Başcı S, et al. Intern Emerg Med. 2022 Jan;17(1):135-139. doi: 10.1007/s11739-021-02784-y. Epub 2021 Jun 10. Intern Emerg Med. 2022. PMID: 34110562 Free PMC article.
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Ayvalı MO, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Başcı S, et al. J Oncol Pharm Pract. 2020 Oct;26(7):1676-1682. doi: 10.1177/1078155220953198. Epub 2020 Aug 27. J Oncol Pharm Pract. 2020. PMID: 32854573 Free PMC article.
METHOD: The data of 16 laboratory-confirmed COVID-19 patients with CML receiving TKI and age, gender, and comorbid disease matched COVID-19 patients without cancer at a 3/1 ratio (n = 48), diagnosed between March 11, 2020 and May 22, 2020 and included in the Republic of Turkey, …
METHOD: The data of 16 laboratory-confirmed COVID-19 patients with CML receiving TKI and age, gender, and comorbid disease matched COVID-19 …